Author

Xiaoli Liu

Institutions: Weifang Medical University, Shandong University, Shandong Tumor Hospital, Shandong First Medical University

Observed institutions: Weifang Medical University, Shandong University, Shandong Tumor Hospital, Shandong First Medical University

ORCID: 0009-0003-0316-6233

Observed ORCID: 0009-0003-0316-6233

OpenAlex ID: A5136851752

Efficacy and safety of omitting the clinical target volume in limited-stage small cell lung cancer: a large-scale multicenter real-world study

2026 · Xiaolong Wang, Xinrui Yu, et al. · Radiotherapy and Oncology

Impact of hepatic radiotherapy on survival and safety outcomes in small cell lung cancer patients with liver metastases: a retrospective study

2026 · Xiaoli Liu, Xinrui Yu, et al. · Therapeutic Advances in Medical Oncology

Comparative efficacy and safety of NALIRIFOX versus other first-line chemotherapy regimens in metastatic pancreatic ductal adenocarcinoma: a retrospective study

2026 · Yuqi Wang, Jiayi Liu, et al. · Therapeutic Advances in Medical Oncology

Works count: 3

Citation count:

H-index:

I10-index: